Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction
Official title: Injectable Augmentation Outcomes in Post-Radiation Head and Neck Cancer Patients With Velopharyngeal Dysfunction
Run by University of Virginia · NCT07264036 · Data updated 2026-11-12
This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | University of Virginia Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Charlottesville, Virginia) |
| Status | Recruiting |
| Started | March 24, 2026 |
| Main results expected | January 1, 2027 |
| Study ends | July 1, 2027 |
| Registry record updated | April 28, 2026 |
| Trial ID | NCT07264036 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
English-speaking adults (age 18+) who are head and neck cancer survivors with perceptual hypernasality and no suspected non-cancer causes of velopharyngeal dysfunction and who have no contraindication to augmentation are ideal candidates.
✕Probably not a fit
Patients with non–cancer-related VPD, those requiring more intensive active cancer surveillance, or those with planned future pharyngeal surgeries or anatomical problems not addressed by augmentation are unlikely to benefit from this intervention in the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, single-site pilot that uses multidisciplinary, multimodal assessments to characterize velopharyngeal dysfunction (VPD) in head and neck cancer survivors. Participants undergo physical exam, flexible nasolaryngoscopy, speech recordings and acoustic analysis, nasometry, clinical swallowing evaluation, and fiberoptic endoscopic evaluation of swallowing (FEES). A subset with confirmed VPD will receive pharyngeal wall augmentation as part of routine clinical care, with pre- and post-intervention comparisons of speech, swallowing, and patient-reported outcomes. The study also aims to determine prevalence and to test the diagnostic usefulness of advanced measures like nasometry in this population.
Why it matters
Potential benefit: If successful, pharyngeal wall augmentation could reduce hypernasal speech, lower nasal regurgitation during swallowing, and improve speech- and swallowing-related quality of life for affected survivors.
How similar studies have gone: Augmentation approaches have shown benefit in small series and in non-cancer VPD populations, but data specifically in head and neck cancer survivors are limited, making this application relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: English-speaking adults (≥18 years) History of head and neck cancer treated with surgical resection, chemoradiation, or both Presence of perceptual hypernasality on clinical assessment Exclusion Criteria: Pre-existing or suspected non-cancer-related causes of velopharyngeal dysfunction Contraindications to pharyngeal wall augmentation Requirement for more intensive active cancer surveillance Planned future surgical or medical treatments to the pharynx that would interfere with participation
Where it's running
-
University of Virginia
Charlottesville, Virginia, United States Recruiting
Study contacts
- Principal investigator: Vanessa Torrecillas, MD — University of Virginia
- Study coordinator: Vanesssa Torrecillas, MD
- Email: vge3bm@uvahealth.org
- Phone: 434-924-2040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Early swallowing and speech intervention for head and neck cancer patients after surgery
This study is testing if early help from speech therapists can improve swallowing and speech for patients with tongue cancer after surgery to prevent complications.
-
Nurse counselling and personalized survivorship care plans for head and neck cancer survivors
This trial will try a nurse-led motivational counselling session combined with a personalized treatment summary and survivorship care plan to help people 3-6 months after head and neck cancer treatment follow recommended care.
-
A program to support head and neck cancer survivors and their caregivers
This study is testing a new support program for head and neck cancer survivors and their caregivers to see if it helps them manage symptoms and reduces stress compared to regular care.
-
Improving body image for head and neck cancer survivors
This study is testing a new video therapy program to see if it can help head and neck cancer survivors feel better about their body image and improve their overall well-being.
-
Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)
This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.
-
Airway ultrasound in head and neck cancer patients
This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.